AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 65(5), 2001, pp. 593-598
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tjitra, E
Right arrow Articles by Anstey, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tjitra, E
Right arrow Articles by Anstey, N.
Related Collections
Right arrow Travel Medicine
Right arrow Health Outcomes
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 5, 593-598
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Detection of histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after chloroquine treatment of uncomplicated falciparum malaria does not reliably predict treatment outcome in eastern Indonesia

E Tjitra, S Suprianto, ME Dyer, BJ Currie, and NM Anstey

In regions with drug-resistant malaria, the ability to rapidly detect or predict treatment failure (TF) soon after a course of standard therapy for Plasmodium falciparum malaria would facilitate the prompt institution of second-line therapy. We thus evaluated longitudinally the ability of the ICT Malaria Pf/Pv immunochromatographic test to predict treatment outcome. Sixty-six Sumbanese Indonesians with uncomplicated falciparum malaria were treated with chloroquine and followed for 28 days by use of 1997 World Health Organization criteria for assessment of therapeutic efficacy of antimalarial drugs. The ICT Pf/Pv testing could be compared with microscopy in approximately half of the patients on each day of follow-up. Although strongly positive histidine rich protein 2 (HRP2) line intensities (equal to or greater than the control band) in convalescence were highly predictive of TF, any degree of positivity for the HRP2 and panmalarial antigens in convalescence was only moderately predictive of TE Positive predictive values of the HRP2 and panmalarial antigens for TF were 76.9% and 87.0%, respectively, on Day 3, 82.4% and 87.5% on Day 7, and 78.9% and 78.9% on Day 14. Negative HRP2 and panmalarial antigen results in convalescence were even less predictive of an adequate clinical response, and false-negative HRP2 and panmalarial antigen test results were found in one-sixth (6 of 37) of recrudescent infections diagnosed by microscopy among patients with late treatment failure. To reliably predict treatment outcome with rapid antigen tests, further development appears necessary to improve sensitivity for viable asexual parasites while avoiding detection of both gametocytes and persistent antigen in convalescence.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
H. HOPKINS, W. KAMBALE, M. R. KAMYA, S. G. STAEDKE, G. DORSEY, and P. J. ROSENTHAL
COMPARISON OF HRP2- AND pLDH-BASED RAPID DIAGNOSTIC TESTS FOR MALARIA WITH LONGITUDINAL FOLLOW-UP IN KAMPALA, UGANDA
Am J Trop Med Hyg, June 1, 2007; 76(6): 1092 - 1097.
[Abstract] [Full Text] [PDF]

Home page
 J Trop PediatrHome page
A. Cheng and D. Bell
Evidence Behind the WHO Guidelines: Hospital Care for Children: What is the Precision of Rapid Diagnostic Tests for Malaria?
J Trop Pediatr, December 1, 2006; 52(6): 386 - 389.
[Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. ARAI, A. ISHII, and H. MATSUOKA
LABORATORY EVALUATION OF THE ICT MALARIA P.F./P.V. IMMUNOCHROMATOGRAPHIC TEST FOR DETECTING THE PANMALARIAL ANTIGEN USING A RODENT MALARIA MODEL
Am J Trop Med Hyg, February 1, 2004; 70(2): 139 - 143.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Tjitra, J. Baker, S. Suprianto, Q. Cheng, and N. M. Anstey
Therapeutic Efficacies of Artesunate-Sulfadoxine-Pyrimethamine and Chloroquine-Sulfadoxine-Pyrimethamine in Vivax Malaria Pilot Studies: Relationship to Plasmodium vivax dhfr Mutations
Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3947 - 3953.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.